EI
SANA icon

EFG International’s Sana Biotechnology SANA Stock Holding History

EFG International’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,000
Closed -$20.4K – 1102
2025
Q4 		$20.4K Buy
+5,000
New +$22.4K ﹤0.01% 765

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return

EFG International's SANA Position: Q1 2026 in Review

EFG International sold out of Sana Biotechnology (SANA) in Q1 2026, closing a stake of 5,000 shares — an estimated $20.4K sold.

EFG International first reported a position in SANA in Q4 2025 and held it in 1 quarter. The position peaked at $20.4K in Q4 2025. 203 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

  • EFG International reported no remaining Sana Biotechnology position as of Q1 2026 after selling out during the quarter.
  • EFG International sold 5,000 Sana Biotechnology shares in Q1 2026, an estimated $20.4K.
  • EFG International first reported a position in Sana Biotechnology in Q4 2025 and held it in 1 quarter.
  • EFG International's Sana Biotechnology position peaked at $20.4K in Q4 2025.
  • 203 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on EFG International's 13F filing for Q1 2026, filed 15 May 2026.